BioAge Labs, Inc.
BIOA
$4.51
-$0.10-2.17%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -79.03M | -71.05M | -71.11M | -70.94M | -62.16M |
Total Depreciation and Amortization | 180.00K | 171.00K | 167.00K | 161.00K | 171.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 10.95M | 9.32M | 8.24M | 13.77M | 17.08M |
Change in Net Operating Assets | 10.49M | 8.34M | 11.18M | 2.12M | -2.82M |
Cash from Operations | -57.40M | -53.21M | -51.52M | -54.89M | -47.72M |
Capital Expenditure | -916.00K | -792.00K | -366.00K | -340.00K | -134.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -93.04M | -77.56M | -- | 0.00 | 0.00 |
Cash from Investing | -93.96M | -78.35M | -366.00K | -340.00K | -134.00K |
Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
Total Debt Repaid | -6.00M | -6.00M | -6.00M | -5.50M | -4.00M |
Issuance of Common Stock | 221.83M | 222.25M | 222.25M | 194.61M | 429.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | 542.00K | 542.00K | 170.54M | 170.54M | 170.00M |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -3.79M | -5.09M | -5.60M | -4.37M | -1.87M |
Cash from Financing | 212.59M | 211.70M | 381.20M | 355.29M | 164.56M |
Foreign Exchange rate Adjustments | 21.00K | 50.00K | 81.00K | -121.00K | -28.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 61.25M | 80.18M | 329.39M | 299.94M | 116.68M |